Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models
Current Protocols in Neuroscience · 2020-03 · 91 (1)
DOI: 10.1002/cpns.88 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Protocols in Neuroscience, online erschienen am 12.02.2020. Verfasst von Mikko Airavaara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Parkinsonian Disorders. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instrumentariumin Tiedesäätiö.
Abstract (Originalsprache)
Parkinson's disease (PD) is an age‐related neurodegenerative disorder characterized by motor symptoms such as tremor, slowness of movement, rigidity, and postural instability, as well as non‐motor features like sleep disturbances, loss of ability to smell, depression, constipation, and pain. Motor symptoms are caused by depletion of dopamine in the striatum due to the progressive loss of dopamine neurons in the substantia nigra pars compacta. Approximately 10% of PD cases are familial arising from genetic mutations in α‐synuclein, LRRK2, DJ‐1, PINK1, parkin, and several other proteins. The majority of PD cases are, however, idiopathic, i.e., having no clear etiology. PD is characterized by progressive accumulation of insoluble inclusions, known as Lewy bodies, mostly composed of α‐synuclein and membrane components. The cause of PD is currently attributed to cellular proteostasis deregulation and mitochondrial dysfunction, which are likely interdependent. In addition, neuroinflammation is present in brains of PD patients, but whether it is the cause or consequence of neurodegeneration remains to be studied. Rodents do not develop PD or PD‐like motor symptoms spontaneously; however, neurotoxins, genetic mutations, viral vector‐mediated transgene expression and, recently, injections of misfolded α‐synuclein have been successfully utilized to model certain aspects of the disease. Here, we critically review the advantages and drawbacks of rodent PD models and discuss approaches to advance pre‐clinical PD research towards successful disease‐modifying therapy. © 2020 The Authors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.
- Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
- Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Förderung
- Instrumentariumin Tiedesäätiö
Zitieren
APA
Airavaara, M., Parkkinen, I., Konovalova, J., Albert, K., Chmielarz, P., & Domanskyi, A. (2020). Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models. Current Protocols in Neuroscience, 91(1). https://doi.org/10.1002/cpns.88
Vancouver
Airavaara M, Parkkinen I, Konovalova J, Albert K, Chmielarz P, Domanskyi A. Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models. Current Protocols in Neuroscience. 2020;91(1). doi:10.1002/cpns.88
BibTeX
@article{Airavaara2020,
author = {Airavaara, Mikko and Parkkinen, Ilmari and Konovalova, Julia and Albert, Katrina and Chmielarz, Piotr and Domanskyi, Andrii},
title = {Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models},
journal = {Current Protocols in Neuroscience},
year = {2020},
volume = {91},
number = {1},
doi = {10.1002/cpns.88}
}
EUVIMED